Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Klinische Padiatrie
|
April 8, 2011
Terminally differentiated CD8 cells in HIV-infected children: HIV-GAG/POL specificity and IFN-γ production
D Delbeck, M Siepermann, O Feyen, et al.
AIDS (London, England)
|
July 14, 2000
Efficacy and safety of twice daily first-line ritonavir/indinavir plus double nucleoside combination therapy in HIV-infected individuals. German Ritonavir/Indinavir Study Group
J K Rockstroh, F Bergmann, W Wiesel, et al.
Deutsche Medizinische Wochenschrift (1946)
|
April 26, 2007
[Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005]
M Oette, R Kaiser, M Däumer, et al.
Gene Therapy
|
March 10, 2006
Plasmid size up to 20 kbp does not limit effective in vivo lung gene transfer using compacted DNA nanoparticles
T L Fink, P J Klepcyk, S M Oette, et al.
Spine
|
May 30, 2009
Treatment of spondylodiscitis in human immunodeficiency virus-infected patients: a comparison of conservative and operative therapy
R Sobottke, K Zarghooni, M Krengel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 29, 2011
Optimization of hCFTR lung expression in mice using DNA nanoparticles
Linas Padegimas, Tomasz H Kowalczyk, Sam Adams, et al.
HIV Medicine
|
June 13, 2002
Long-term efficacy and safety of ritonavir/indinavir at 400/400 mg twice a day in combination with two nucleoside reverse transcriptase inhibitors as first line antiretroviral therapy
M Lichterfeld, H D Nischalke, F Bergmann, et al.
HIV Medicine
|
September 25, 2014
Hodgkin lymphoma is as common as non-Hodgkin lymphoma in HIV-positive patients with sustained viral suppression and limited immune deficiency: a prospective cohort study
C Hoffmann, M Hentrich, D Gillor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 28, 2006
Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin's disease: results of a multicenter study
M Hentrich, L Maretta, K U Chow, et al.
Infection
|
February 4, 2021
Torque Teno Virus plasma level as novel biomarker of retained immunocompetence in HIV-infected patients
L Schmidt, B-E O Jensen, A Walker, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Klinische Padiatrie
|
April 8, 2011
Terminally differentiated CD8 cells in HIV-infected children: HIV-GAG/POL specificity and IFN-γ production
D Delbeck, M Siepermann, O Feyen, et al.
AIDS (London, England)
|
July 14, 2000
Efficacy and safety of twice daily first-line ritonavir/indinavir plus double nucleoside combination therapy in HIV-infected individuals. German Ritonavir/Indinavir Study Group
J K Rockstroh, F Bergmann, W Wiesel, et al.
Deutsche Medizinische Wochenschrift (1946)
|
April 26, 2007
[Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005]
M Oette, R Kaiser, M Däumer, et al.
Gene Therapy
|
March 10, 2006
Plasmid size up to 20 kbp does not limit effective in vivo lung gene transfer using compacted DNA nanoparticles
T L Fink, P J Klepcyk, S M Oette, et al.
Spine
|
May 30, 2009
Treatment of spondylodiscitis in human immunodeficiency virus-infected patients: a comparison of conservative and operative therapy
R Sobottke, K Zarghooni, M Krengel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 29, 2011
Optimization of hCFTR lung expression in mice using DNA nanoparticles
Linas Padegimas, Tomasz H Kowalczyk, Sam Adams, et al.
HIV Medicine
|
June 13, 2002
Long-term efficacy and safety of ritonavir/indinavir at 400/400 mg twice a day in combination with two nucleoside reverse transcriptase inhibitors as first line antiretroviral therapy
M Lichterfeld, H D Nischalke, F Bergmann, et al.
HIV Medicine
|
September 25, 2014
Hodgkin lymphoma is as common as non-Hodgkin lymphoma in HIV-positive patients with sustained viral suppression and limited immune deficiency: a prospective cohort study
C Hoffmann, M Hentrich, D Gillor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 28, 2006
Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin's disease: results of a multicenter study
M Hentrich, L Maretta, K U Chow, et al.
Infection
|
February 4, 2021
Torque Teno Virus plasma level as novel biomarker of retained immunocompetence in HIV-infected patients
L Schmidt, B-E O Jensen, A Walker, et al.
Page
of 4